Current opinion in nephrology and hypertension · 2011
Angiotensin type 2 receptor in hypertensive cardiovascular disease.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Savoia Carmine, D'Agostino Michela, Lauri Francesco, Volpe Massimo
Аннотация
PURPOSE OF REVIEW: The renin angiotensin system plays a key role in the development of hypertension-induced cardiovascular remodeling and cardiovascular damage. Angiotensin II (Ang II) exerts its effects by acting on two distinct subtypes of receptor, the angiotensin type 1 receptor (AT1R) and the angiotensin type 2 receptor (AT2R). Whereas AT1R mediates most of the recognized actions of Ang II, it appears that AT2R opposes, in part, the actions mediated by AT1R. As the AT2R is expressed in adult tissues in smaller numbers than AT1R, the actions and cell signaling of AT2R have been less well characterized than those of AT1R.
RECENT FINDINGS: Current knowledge suggests that AT2R stimulation mediates vasodilation, antigrowth, proapoptotic and antiinflammatory effects. Hence, AT2R can modulate cardiovascular remodeling as well as the progression of atherosclerosis. A protective role of AT2R in the cardiovascular system has been also documented in humans, mainly during chronic AT1R inhibition. Furthermore, a new nonpeptide AT2R agonist has been developed, with potential future therapeutic applications in hypertensive conditions.
SUMMARY: This article reviews the role of AT2R expression signaling and function in the pathogenesis of the functional and structural alterations induced by hypertension on the cardiovascular system.
RECENT FINDINGS: Current knowledge suggests that AT2R stimulation mediates vasodilation, antigrowth, proapoptotic and antiinflammatory effects. Hence, AT2R can modulate cardiovascular remodeling as well as the progression of atherosclerosis. A protective role of AT2R in the cardiovascular system has been also documented in humans, mainly during chronic AT1R inhibition. Furthermore, a new nonpeptide AT2R agonist has been developed, with potential future therapeutic applications in hypertensive conditions.
SUMMARY: This article reviews the role of AT2R expression signaling and function in the pathogenesis of the functional and structural alterations induced by hypertension on the cardiovascular system.